No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / metabolism
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Biomarkers / metabolism
-
Breast Neoplasms / drug therapy*
-
Female
-
Humans
-
Predictive Value of Tests
-
Product Surveillance, Postmarketing
-
Randomized Controlled Trials as Topic
-
Survival Analysis
-
Time Factors